tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 505 are a BUY (98.44%), 5 are a HOLD (0.97%), 3 are a SELL (0.58%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 25.24% that have a potential upside of 63.9% achieved within 136 days.
Gil Blum’s has documented 950 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals.
Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Feb-2022
$60
2 years 10 months 4 days ago
(18-Dec-2023)
0/2 (0%)
$60 (0.00%)
$2.04
$0.64 (45.71%)
$36
3 years 3 months 9 days ago
(13-Jul-2023)
0/2 (0%)
$2.04 (0.00%)
$2.04
$0.64 (45.71%)
$32
3 years 3 months 10 days ago
(12-Jul-2023)
0/3 (0%)
$2.04 (0.00%)
$6
$4.6 (328.57%)
$6
3 years 6 months 28 days ago
(24-Mar-2023)
0/5 (0%)
$6 (0.00%)
Hold Since 08-Dec-2022
$4
3 years 10 months 14 days ago
(08-Dec-2022)
0/3 (0%)
$4 (0.00%)
Which stock is Gil Blum most bullish on?
Which stock is Gil Blum most reserved on?
What Year was the first public recommendation made by Gil Blum?
